SCHOFIELD, Wis.--(BUSINESS WIRE)--PuraMed Bioscience, Inc.(OTCBB:PMBS), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines targeting major consumer health needs including the treatment of headaches, insomnia and general pain announced today that they were successful in securing initial investment capital via private funding.
